Last update:

Diseases, Conditions, Syndromes

Half of US adults now have received at least 1 COVID shot

Half of all adults in the U.S. have received at least one COVID-19 shot, the government announced Sunday, marking another milestone in the nation's largest-ever vaccination campaign but leaving more work to do to convince ...

Neuroscience

Neural plasticity depends on this long noncoding RNA's journey from nucleus to synapse

Making memories involves more than seeing friends or taking photos. The brain constantly adapts to new information and stores memories by building connections among neurons, called synapses. How neurons do this—reaching ...

Genetics

COVID-19: Scientists identify human genes that fight infection

Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers' understanding ...

Neuroscience

How a tangled protein kills brain cells, promotes Alzheimer's

Look deep inside the brain of someone with Alzheimer's disease, most forms of dementia or the concussion-related syndrome known as chronic traumatic encephalopathy (CTE) and you'll find a common suspected culprit: stringy, ...

Neuroscience

A neuromagnetic view through the skull

The brain processes information using both slow and fast currents. Until now, researchers had to use electrodes placed inside the brain in order to measure the latter. For the first time, researchers from Charité - Universitätsmedizin ...

Diseases, Conditions, Syndromes

Coronavirus does not infect the brain but still inflicts damage

SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists ...

Oncology & Cancer

An antibody-drug combo to combat cancer

Leukemias are debilitating cancers of the hematopoietic or blood-forming cells of the bone marrow. Now, researchers at Tokyo Medical and Dental University (TMDU) describe an ingenious strategy against chronic myelomonocytic ...

Diseases, Conditions, Syndromes

Pfizer CEO: Vaccine third dose 'likely' needed within 12 months

The head of Pfizer said in an interview aired Thursday that people will "likely" need a third dose of his company's COVID-19 shot within six to 12 months of vaccination, while elsewhere defending the relatively higher cost ...